09 Aug Evolution Biotechnologies announces that its UK patent application for house dust mites has progressed to the international stage

Evolution Biotechnologies (www.evolutionbiotech.com), the company working to expand the use of biological control into medically important areas, today announced that its UK patent application, “Acaricides” (GB1513981.9), relating to biological controls for house dust mites has progressed to the international stage as PCT application PCT/GB2016/052455. The PCT filing incorporates both data from the previous successful feasibility study and also recent findings identifying a biological agent capable of targeting multiple mite species. Dr. David Harper, Chief Officer of Evolution, said “we are delighted to be able to incorporate the recent and exciting findings from our HDM research group, headed by Senior Scientist Dr....